This review critically examines the current evidence supporting the use of GLP-1 RAs, including their efficacy, safety, cost-effectiveness, and ethical implications in the pediatric population
St., Streptococcus
Landmark studies in patients with T2DM including Veteran Affairs Diabetes trial (VADT), the Action in Diabetes and Vascular Disease: Preterax and Diamicron MR controlled Evaluation (ADVANCE) trial, and the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial have provided consistent evidence that intensive glycemic control is the path to follow
The key is choosing whole, unprocessed sources and keeping portions small
After four weeks, the dose increases to 0.5 mg weekly for another four weeks, then progresses to 1 mg weekly in four-week increments until reaching your therapeutic dose
It has few side effects such as digestive problems and is safe to consume as directed